Financials PExA AB Deutsche Boerse AG
Equities
FA0
SE0007412374
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0292 EUR | +0.69% | -5.19% | -21.08% |
05-15 | PExA AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-21 | PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Capitalization 1 | 27.59 | 20.67 | 49.97 | 27.23 | 17.5 |
Enterprise Value (EV) 1 | 19.43 | 18 | 29.26 | 8.976 | 7.902 |
P/E ratio | -4.71 x | -6.45 x | -4.95 x | -5.73 x | -2.18 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 10.4 x | 5.75 x | 23.1 x | 4.52 x | 8.69 x |
EV / Revenue | 7.29 x | 5.01 x | 13.5 x | 1.49 x | 3.92 x |
EV / EBITDA | -3.36 x | -3.03 x | -3.91 x | -2.31 x | -0.97 x |
EV / FCF | -7.75 x | -0.98 x | -9.25 x | -1.95 x | -1.17 x |
FCF Yield | -12.9% | -102% | -10.8% | -51.3% | -85.5% |
Price to Book | 2.5 x | 1.93 x | 2.28 x | 1.28 x | 1.32 x |
Nbr of stocks (in thousands) | 9,226 | 9,226 | 34,704 | 42,276 | 42,276 |
Reference price 2 | 2.990 | 2.240 | 1.440 | 0.6440 | 0.4140 |
Announcement Date | 19-05-06 | 20-05-05 | 23-05-05 | 23-05-05 | 24-05-08 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 2.665 | 3.593 | 2.161 | 6.027 | 2.015 |
EBITDA 1 | -5.788 | -5.934 | -7.476 | -3.887 | -8.155 |
EBIT 1 | -5.871 | -6.017 | -7.799 | -4.442 | -8.519 |
Operating Margin | -220.32% | -167.47% | -360.83% | -73.7% | -422.76% |
Earnings before Tax (EBT) 1 | -5.858 | -6.007 | -7.759 | -4.305 | -8.044 |
Net income 1 | -5.858 | -6.007 | -7.759 | -4.305 | -8.044 |
Net margin | -219.83% | -167.2% | -358.97% | -71.43% | -399.14% |
EPS 2 | -0.6350 | -0.3473 | -0.2908 | -0.1125 | -0.1903 |
Free Cash Flow 1 | -2.508 | -18.27 | -3.162 | -4.607 | -6.753 |
FCF margin | -94.12% | -508.61% | -146.28% | -76.44% | -335.12% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 19-05-06 | 20-05-05 | 23-05-05 | 23-05-05 | 24-05-08 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 8.16 | 2.67 | 20.7 | 18.2 | 9.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | -2.51 | -18.3 | -3.16 | -4.61 | -6.75 |
ROE (net income / shareholders' equity) | -41.9% | -38.6% | -45.5% | -19.9% | -46.6% |
ROA (Net income/ Total Assets) | -23.2% | -21.6% | -24.1% | -10.8% | -26.6% |
Assets 1 | 25.28 | 27.83 | 32.25 | 39.69 | 30.23 |
Book Value Per Share 2 | 1.200 | 1.160 | 0.6300 | 0.5000 | 0.3100 |
Cash Flow per Share 2 | 0.8800 | 0.1500 | 0.6000 | 0.4300 | 0.2300 |
Capex | - | - | 0.85 | 0.64 | - |
Capex / Sales | - | - | 39.46% | 10.56% | - |
Announcement Date | 19-05-06 | 20-05-05 | 23-05-05 | 23-05-05 | 24-05-08 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-34.27% | 14.75B | |
-54.93% | 2.22B | |
+15.49% | 1.82B | |
-14.07% | 1.43B | |
+21.99% | 1.23B | |
+1.25% | 784M | |
-35.50% | 741M | |
-36.65% | 723M | |
-28.15% | 602M |
- Stock Market
- Equities
- PEXA B Stock
- FA0 Stock
- Financials PExA AB